Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer

Abstract Purpose New treatment strategies, particularly the introduction of molecular-targeted agents and appropriate patient selection based on histology and/or genotyping, have progressed markedly in recent years, and the overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Masayuki Aboshi, Masayuki Kaneko, Mamoru Narukawa
Format: Article
Language:English
Published: Springer 2014-02-01
Series:Journal of Cancer Research and Clinical Oncology
Subjects:
Online Access:https://doi.org/10.1007/s00432-014-1617-3
Tags: Add Tag
No Tags, Be the first to tag this record!